The Clorox Company (NYSE:CLX) Receives $103.40 Average PT from Brokerages

The Clorox Company (NYSE:CLX) has received an average rating of “Reduce” from the seventeen brokerages that are presently covering the firm, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $103.40.

A number of brokerages have weighed in on CLX. TD Cowen boosted their price objective on Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research note on Tuesday, March 31st. Royal Bank Of Canada reduced their price target on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research report on Thursday, April 9th. JPMorgan Chase & Co. decreased their price target on Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, May 1st. Morgan Stanley reduced their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research report on Friday, May 1st. Finally, UBS Group lowered their price target on Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a research report on Friday, May 1st.

Insider Activity at Clorox

In related news, Director Pierre R. Breber bought 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The stock was bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the transaction, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.63% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Clorox by 4.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after purchasing an additional 514 shares during the period. Woodline Partners LP increased its position in shares of Clorox by 253.7% during the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after acquiring an additional 7,465 shares during the last quarter. Baird Financial Group Inc. grew its holdings in Clorox by 1.7% during the 2nd quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after acquiring an additional 424 shares in the last quarter. Jump Financial LLC raised its position in Clorox by 173.5% in the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock valued at $1,500,000 after purchasing an additional 7,924 shares during the last quarter. Finally, Bank of Nova Scotia raised its position in Clorox by 26.2% during the 2nd quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock worth $1,938,000 after buying an additional 3,352 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 2.8%

Shares of CLX opened at $94.82 on Thursday. The stock has a market capitalization of $11.47 billion, a PE ratio of 15.39, a P/E/G ratio of 0.51 and a beta of 0.56. Clorox has a fifty-two week low of $84.70 and a fifty-two week high of $132.03. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The company’s fifty day moving average is $96.05 and its 200 day moving average is $104.96.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company’s quarterly revenue was up .1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Sell-side analysts expect that Clorox will post 5.61 earnings per share for the current fiscal year.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.